Inflammatory modulation effect of Glycopeptide from Ganoderma capense (Lloyd) Teng

Citations of this article
Mendeley users who have this article in their library.


Glycopeptide from Ganoderma capense (Lloyd) Teng (GCGP) injection is widely used in kinds of immune disorders, but little is known about the molecular mechanisms of how GCGP could interfere with immune cell function. In the present study, we have found that GCGP had inflammatory modulation effects on macrophage cells to maintain NO production and iNOS expression at the normal level. Furthermore, western blot analysis showed that the underlying mechanism of immunomodulatory effect of GCGP involved NF-B p65 translation, IB phosphorylation, and degradation; NF-B inhibitor assays also confirmed the results. In addition, competition study showed that GCGP could inhibit LPS from binding to macrophage cells. Our data indicates that GCGP, which may share the same receptor(s) expressed by macrophage cells with LPS, exerted immunomodulatory effect in a NF-B-dependent signaling pathway in macrophages. © 2014 Yan Zhou et al.




Zhou, Y., Chen, S., Ding, R., Yao, W., & Gao, X. (2014). Inflammatory modulation effect of Glycopeptide from Ganoderma capense (Lloyd) Teng. Mediators of Inflammation, 2014.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free